This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AptarGroup CEO Discusses Q4 2011 Results - Earnings Call Transcript

Our newest segment, Food and Beverage, also had a good year posting organic sales growth up 18% primarily driven by strong demand for our unique dispensing systems for beverage products. An example of a new category that we entered in 2011 is the water flavoring category. Kraft Foods launched their MiO Water Enhancer using our custom simply squeeze closure and they've expanded their line recently and we're now selling an energy version.

In spite of our strong sales growth profitability was restrained by costs to establish this new segment and start up costs associated with a new facility in the US. With our ability to generate strong free cash flow we're able to invest in several growth opportunities during the year.

In May, we announced that we had purchased a facility in Lincolnton, North Carolina that will become our first facility dedicated to serving to our food and beverage customers. I'm happy to say that the retrofitting of the facility has gone according to plan. We've hired a terrific team and we're on schedule to begin production in the first quarter of this year.

In October, we announced that we had purchased an injection molder in India to expand our presence there to serve our multi national and also local customers. The company we purchased had been a licensee of our products since 2006. Also at that the time we announced that we're opening a clean room manufacturing facility in India to server our Indian pharmaceutical customers as they grow in India and abroad.

I'm also happy to report that this facility was dedicated in January and production will begin in the first quarter. We've also upgraded and expanded our capacity in other important regions, such as Brazil, Mexico, Russia and China. And in November, we announced that we'd entered into the auto injector field through an acquisition of a minority stake in UK-based medical device company called Oval Medical Technologies.

3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.20 -1.10%
FB $99.87 -1.10%
GOOG $674.46 -1.40%
TSLA $154.35 7.40%
YHOO $26.73 -1.40%


Chart of I:DJI
DOW 15,582.49 -332.25 -2.09%
S&P 500 1,819.32 -32.54 -1.76%
NASDAQ 4,228.7990 -54.7930 -1.28%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs